Liu Song Yin

Amministratore Delegato presso Sunho Biologics, Inc.

37 anni

Health Technology

Consumer Services

Profilo

Liu Song Yin is currently the CEO, Executive Director & Chief Scientific Officer at Sunho Biologics, Inc. He is also a Director at Sunho Bio Investments Ltd., Sunho Hk Ltd., Sunho Pharmaceutical Technology Zhejiang Anji Co. Ltd., and Nanjing Sunho Medical Technology Co., Ltd.
In 2020, he became the Chief Executive & Scientific Officer at SunHo (China) Biopharmaceutical Co. Ltd.
Prior to his current positions, he worked as an Executive Director at Genscript Biotech Corp.
from 2015 to 2020.
Dr. Yin completed his undergraduate degree at the University of Science & Technology of China in 2008 and obtained his doctorate from UMass Chan Medical School in 2014.

Posizioni attive di Liu Song Yin

Società	Posizione	Inizio
Sunho Biologics, Inc. Sunho Biologics, Inc. BiotechnologyHealth Technology Sunho Biologics, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou, China.	Amministratore Delegato	22/07/2023
SunHo (China) Biopharmaceutical Co. Ltd.	Amministratore Delegato	01/11/2020